Diamyd Medical AB

Diamyd Medical AB
Stock Exchange First North Sweden
EPS
SEK0.68
Market Cap
SEK451.8 M
Shares Outstanding
54.2 M
Public Float
-

Profile

Address
Kungsgatan 29
Stockholm AB 111 56
Sweden
Employees -
Website http://www.diamyd.com
Updated 09/14/2018
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes. It develops vaccine to cure autoimmune diabetes. The firm also involves in investment in medical and stem cell technology.

Financials

View All

Maria-Teresa Essen-Möller
Director
Anders Essen-Möller
Director